Prescott Group Capital Management, L.L.C. Opti Nose, Inc. Transaction History
Prescott Group Capital Management, L.L.C.
- $621 Million
- Q3 2024
A detailed history of Prescott Group Capital Management, L.L.C. transactions in Opti Nose, Inc. stock. As of the latest transaction made, Prescott Group Capital Management, L.L.C. holds 1,252,088 shares of OPTN stock, worth $500,835. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,252,088
Previous 783,065
59.9%
Holding current value
$500,835
Previous $814,000
2.95%
% of portfolio
0.13%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding OPTN
# of Institutions
62Shares Held
88.3MCall Options Held
0Put Options Held
0-
Mvm Partners, LLC Boston, MA14.6MShares$5.84 Million10.4% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT14.4MShares$5.74 Million0.57% of portfolio
-
Great Point Partners LLC Greenwich, CT12.9MShares$5.14 Million3.98% of portfolio
-
Stonepine Capital Management, LLC Bend, OR5.69MShares$2.28 Million2.41% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY5.6MShares$2.24 Million0.45% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $33.3M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...